JP2012087129A5 - - Google Patents

Download PDF

Info

Publication number
JP2012087129A5
JP2012087129A5 JP2011249051A JP2011249051A JP2012087129A5 JP 2012087129 A5 JP2012087129 A5 JP 2012087129A5 JP 2011249051 A JP2011249051 A JP 2011249051A JP 2011249051 A JP2011249051 A JP 2011249051A JP 2012087129 A5 JP2012087129 A5 JP 2012087129A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
dihydro
dimethyl
benzoxazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011249051A
Other languages
English (en)
Japanese (ja)
Other versions
JP5523430B2 (ja
JP2012087129A (ja
Filing date
Publication date
Priority claimed from US09/552,354 external-priority patent/US6436929B1/en
Application filed filed Critical
Publication of JP2012087129A publication Critical patent/JP2012087129A/ja
Publication of JP2012087129A5 publication Critical patent/JP2012087129A5/ja
Application granted granted Critical
Publication of JP5523430B2 publication Critical patent/JP5523430B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2011249051A 1999-05-04 2011-11-14 プロゲステロン受容体モジュレーターとしてのシクロチオカルバメート誘導体 Expired - Fee Related JP5523430B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18301399P 1999-05-04 1999-05-04
US60/183,013 1999-05-04
US09/552,354 2000-04-19
US09/552,354 US6436929B1 (en) 1999-05-04 2000-04-19 Cyclothiocarbamate derivatives as progesterone receptor modulators

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000615600A Division JP4958338B2 (ja) 1999-05-04 2000-05-01 プロゲステロン受容体モジュレーターとしてのシクロチオカルバメート誘導体

Publications (3)

Publication Number Publication Date
JP2012087129A JP2012087129A (ja) 2012-05-10
JP2012087129A5 true JP2012087129A5 (cg-RX-API-DMAC10.html) 2012-06-21
JP5523430B2 JP5523430B2 (ja) 2014-06-18

Family

ID=26878649

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000615600A Expired - Fee Related JP4958338B2 (ja) 1999-05-04 2000-05-01 プロゲステロン受容体モジュレーターとしてのシクロチオカルバメート誘導体
JP2011249051A Expired - Fee Related JP5523430B2 (ja) 1999-05-04 2011-11-14 プロゲステロン受容体モジュレーターとしてのシクロチオカルバメート誘導体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2000615600A Expired - Fee Related JP4958338B2 (ja) 1999-05-04 2000-05-01 プロゲステロン受容体モジュレーターとしてのシクロチオカルバメート誘導体

Country Status (24)

Country Link
EP (1) EP1175411B1 (cg-RX-API-DMAC10.html)
JP (2) JP4958338B2 (cg-RX-API-DMAC10.html)
KR (1) KR100732692B1 (cg-RX-API-DMAC10.html)
CN (1) CN1131856C (cg-RX-API-DMAC10.html)
AT (1) ATE386729T1 (cg-RX-API-DMAC10.html)
AU (1) AU766801B2 (cg-RX-API-DMAC10.html)
BG (1) BG65277B1 (cg-RX-API-DMAC10.html)
BR (1) BR0010214A (cg-RX-API-DMAC10.html)
CA (1) CA2371712C (cg-RX-API-DMAC10.html)
CZ (1) CZ20013952A3 (cg-RX-API-DMAC10.html)
DE (1) DE60038108T2 (cg-RX-API-DMAC10.html)
DK (1) DK1175411T3 (cg-RX-API-DMAC10.html)
EA (1) EA004511B1 (cg-RX-API-DMAC10.html)
ES (1) ES2301482T3 (cg-RX-API-DMAC10.html)
GE (1) GEP20043181B (cg-RX-API-DMAC10.html)
HU (1) HUP0203332A3 (cg-RX-API-DMAC10.html)
IL (1) IL146298A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA01011287A (cg-RX-API-DMAC10.html)
NO (1) NO321370B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ515353A (cg-RX-API-DMAC10.html)
PL (1) PL351083A1 (cg-RX-API-DMAC10.html)
SG (1) SG120970A1 (cg-RX-API-DMAC10.html)
SK (1) SK15922001A3 (cg-RX-API-DMAC10.html)
TR (1) TR200103285T2 (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
KR100732692B1 (ko) * 1999-05-04 2007-06-27 와이어쓰 프로게스테론 수용체 조절인자인 시클로티오카르바메이트유도체
JP4950027B2 (ja) * 2004-04-08 2012-06-13 ワイス・エルエルシー チオアミド不純物を最小限に抑えるための方法
EP1732921B1 (en) * 2004-04-08 2008-11-05 Wyeth Thioamide derivatives as progesterone receptor modulators
BRPI0510260A (pt) * 2004-04-27 2007-10-23 Wyeth Corp método para purificar um composto, e, kit farmacêutico
JP5108506B2 (ja) * 2004-04-27 2012-12-26 ワイス・エルエルシー シアノピロール含有環式カルバメートおよびチオカルバメートビアリール、およびこれらの製造方法
AR049707A1 (es) * 2004-07-07 2006-08-30 Wyeth Corp Regimenes y kits de progestina ciclica
AU2005272854B2 (en) * 2004-08-13 2012-04-26 Wyeth Tanaproget derivatives, metabolites, and uses thereof
BRPI0610438A2 (pt) 2005-04-28 2012-10-23 Wyeth Corp composição farmacêutica, cápsula, conjunto farmacêutico, e, processo para preparar uma composição
US7767668B2 (en) * 2005-04-28 2010-08-03 Wyeth Llc Micronized tanaproget, compositions, and methods of preparing the same
ES2431324T3 (es) * 2005-04-28 2013-11-26 Wyeth Llc Forma purificada de tanaproget
WO2006116596A2 (en) * 2005-04-28 2006-11-02 Wyeth Micronized tanaproget and compostions containing same
MX2007013469A (es) * 2005-04-28 2008-01-22 Wyeth Corp Forma ii polimorfa de tanaproget.
MX2007015571A (es) * 2005-06-09 2008-03-06 Wyeth Corp Composiciones de tanaproget que contienen etinilestradiol.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
JPH0510235A (ja) * 1991-07-05 1993-01-19 Nippondenso Co Ltd 内燃機関の点火時期制御装置
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5688808A (en) * 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
AU717251B2 (en) * 1994-12-22 2000-03-23 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
DE69724630T2 (de) * 1996-10-02 2004-07-29 Bristol-Myers Squibb Pharma Co. 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv-reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung
KR100732692B1 (ko) * 1999-05-04 2007-06-27 와이어쓰 프로게스테론 수용체 조절인자인 시클로티오카르바메이트유도체
WO2006116596A2 (en) * 2005-04-28 2006-11-02 Wyeth Micronized tanaproget and compostions containing same
MX2007015571A (es) * 2005-06-09 2008-03-06 Wyeth Corp Composiciones de tanaproget que contienen etinilestradiol.

Similar Documents

Publication Publication Date Title
RU2005101625A (ru) Производные циклотиокарбамата как модуляторы рецепторов прогестерона и их применение для лечения кожных заболеваний
RU2005101638A (ru) Использование циклокарбаматных производных для лечения гормонзависимых состояний
JP2023516381A5 (cg-RX-API-DMAC10.html)
JP2023525137A5 (cg-RX-API-DMAC10.html)
RU2426731C2 (ru) Производные арил-изоксазоло-4-ил-оксадиазола
RU2007107177A (ru) Соединения и композиции, как модуляторы ядерных рецепторов стероидных гормонов
RU2492167C2 (ru) Производные аминотриазола в качестве агонистов alх
JP2013525438A5 (cg-RX-API-DMAC10.html)
CA2737999A1 (en) Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for the treatment of myeloma
AR110403A1 (es) Fungicidas de oxadiazoles
DK2922848T3 (da) Oxazolidin-2-on-pyrimidinderivater
JP2014526500A5 (cg-RX-API-DMAC10.html)
RU2016111138A (ru) Гетероциклические соединения и способы их применения
CA2636077A1 (en) Thiazole compounds as protein kinase b (pkb) inhibitors
JP2009525960A5 (cg-RX-API-DMAC10.html)
RU2012134306A (ru) Азотосодержащие производные гетероарилов
PE20081228A1 (es) Compuesto heteromonociclico
CA2583217A1 (en) 1,3,4-thiadiazole compounds as protein kinase inhibitors
HRP20180371T1 (hr) Novi derivati piridina
RU2013138834A (ru) N-[3-(5-амино-3,3а,7,7а-тетрагидро-1н-2,4-диокса-6-аза-инден-7-ил)-фенил]-амиды в качестве ингибиторов васе1 и(или) васе2
JP2011513221A5 (cg-RX-API-DMAC10.html)
JP2017501983A5 (cg-RX-API-DMAC10.html)
JP2010502576A5 (cg-RX-API-DMAC10.html)
RU2017118562A (ru) Соединения-антагонисты дофаминового d3-рецептора
JP2009514802A5 (cg-RX-API-DMAC10.html)